Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Aignostics, a Germany-based pathology software spinout of Charité – Universitätsmedizin Berlin and Helmholtz Association of German Research Centres, closed a €5m ($6m) seed round on Friday led by Boehringer Ingelheim Venture Fund, the strategic venturing am for pharmaceutical firm Boehringer Ingelheim. The round was filled out by public-private partnership High-Tech Gründerfonds, Future Capital and VC Fonds Technologie der IBB, a subsidiary of state-run development bank Investitionsbank Berlin. Founded in 2018, Aignostics has built artificial intelligence models intended to help pathologists…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?